Larvol Delta - VOTE-Safety-and-Efficacy-of-a-Phased-Transition-From-Epogen-to-Three-Times-Weekly-Oral-Vadadustat-for-the-Treatment-of-Anemia-in-Subjects-Receiving-InCenter-Hemodialysis

Vafseo (vadadustat) - Akebia Therap

Epogen (epoetin alfa) - Amgen

http://clinicaltrials.gov/ct2/show/NCT07565701

May 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next